ERBB2 and glioblastoma: Subsequent investigations have revealed that, in comparison to monospecific CAR T-cells, a bispecific TanCAR configuration incorporating a “Her-2-binding single-chain variable fragment (scFv)/mutated IL-13” heterodimer has demonstrated enhanced survival rates in GBM models.